- Email:
Parkinson's Disease Modeling Service
Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disorder, marked by the loss of dopaminergic neurons. Traditional models lack human-specific complexity and aged epigenetic states. Creative Biolabs offers advanced PD modeling using 3D iPSC-derived assembloids, direct reprogramming, and patient-specific genomic engineering. The service provides characterized iDA neuron organoids with key PD pathologies, supporting high-confidence phenotypic screening and reliable preclinical therapeutic validation.
Discover How We Can Help - Request a Consultation →
Parkinson's Disease Modeling Service
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of α-synuclein aggregates. Genetic factors such as SNCA, LRRK2, PINK1, and Parkin mutations are closely associated with familial PD.
Common PD Models
- Cell models: Primary midbrain neurons, SH‑SY5Y, LUHMES, patient iPSC-derived dopaminergic neurons, CRISPR‑edited isogenic lines
- Animal models: 6‑OHDA, MPTP, rotenone models; transgenic mice (SNCA A53T, LRRK2 G2019S)
- 3D models: Midbrain organoids, 3D neurospheres, PD‑on‑a‑chip with BBB
Service Contents
- Isogenic PD cell line and iPSC model generation
- 3D midbrain organoid culture and maturation
- α‑synuclein aggregation, mitochondrial function, and neuronal viability assays
- Behavioral and immunohistochemical assessment in animal models
- Drug screening, gene therapy, and cell replacement validation
Applications
- Mechanistic studies of dopaminergic neurodegeneration
- High-throughput drug screening and neuroprotection evaluation
- Gene therapy (CRISPR, ASO) and AAV vector testing
- Patient-specific precision medicine and biomarker development
Workflow
Our streamlined process ensures transparency and scientific rigor from initiation to final data delivery.
What We Can Offer
At Creative Biolabs, we understand that every neurodegenerative research project is unique. Our Parkinson's Disease Modeling platform is built on a foundation of industrial-scale capability and strict quality assurance, offering the following core advantages:
One-Stop Customized Modeling
Full-scale services ranging from initial cell bank characterization to large-scale 3D organoid production and high-throughput screening.
Fully Characterized Cell Banks
Documentation quality and procedures for donor origin are assessed and approved by a qualified quality assurance service, ensuring maximum clinical relevance.
Genetic Stability & Integrity
We guarantee the stability of strains and iPSC lines through regular genomic integrity assessments (Karyotyping/WGS) throughout the differentiation and expansion process.
Optimized Expression Systems
Precision engineering to optimize the expression of PD-related genes (e.g., SNCA, LRRK2) to maximize the manifestation of pathological phenotypes.
Scalable Industrial Infrastructure
Utilization of high-capacity orbital shaking systems and large-scale culture environments to ensure consistency across thousands of uniform organoids.
Rigorous Quality Control (QC)
Implementation of Quality-by-Design (QbD) and process analytical techniques (PAT) to monitor neuronal maturation and branch complexity in real-time.
Compliance & GMP Standards
All modeling processes follow the basic principles of Good Manufacturing Practice (GMP) and strict aseptic verification procedures.
Flexible Collaborative Models
We provide customized research partnerships, including joint development of novel assembloids (integrating microglia, oligodendrocytes, or BBB components) tailored to your specific therapeutic targets.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Case Study
The researchers directly reprogrammed human fibroblasts into 3D iDA organoids by using lentiviral vectors to transduce ASCL1, PITX3, NURR1, and LMX1A. They used Matrigel encapsulation and unencapsulated aggregation tubes for culture to enhance the formation efficiency. They detected DA neuron markers, gene expression, cell composition, and mature phenotypes through immunofluorescence, qRT-PCR, and morphological analysis. The results showed that this system could efficiently generate highly pure and mature dopaminergic neurons, expressing key features such as VMAT2, DAT, and neuroblastic melanin, bypassing the neural progenitor cell stage, and outperforming the 2D system. The 3D iDA organoids can stably reproduce the phenotypes of midbrain DA neurons and are suitable for research on the mechanism of Parkinson's disease, phenotypic screening, and drug evaluation.
Fig.1 Generation of 3D-iDA organoids from directly induced iDA neurons.1
Customer Reviews
FAQs
Q: How do your models preserve the "biological age" of the donor?
A: We utilize direct conversion of fibroblasts to neurons, which avoids the pluripotent state that typically erases epigenetic aging marks, ensuring the model reflects the aged environment of a PD patient.
Q: Can you incorporate multiple cell types into a single model?
A: Yes, our assembloid service allows for the integration of neurons, astrocytes, and microglia, enabling the study of neuroinflammation and glial-neuronal interactions.
Q: How do you ensure the stability of the 3D organoids over long-term cultures?
A: We use optimized culture conditions and specialized media formulations to support the viability and functional maturation of neurons for 30+ days in 3D space.
Q: Are these models suitable for high-throughput screening (HTS)?
A: Yes. Our 3D organoid platform is designed for scalability and is compatible with automated high-content screening (HCS) systems for rapid lead identification.
Q: Do you offer custom genetic modifications for rare PD variants?
A: Yes, we utilize CRISPR/Cas9 technology to generate custom knock-in or knock-out models for any specific genetic variant or mutation required by your research.
Creative Biolabs offers the industry's most sophisticated platform for Parkinson's Disease Modeling, combining 3D organoid technology, direct reprogramming, and multi-lineage assembloids. Our services are designed to provide high-fidelity human data that accelerates your path to the clinic and solves the heterogeneity problem in PD research.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Kim, Hongwon, et al. "Parkinson's disease modeling using directly converted 3D induced dopaminergic neuron organoids and assembloids." Advanced Science 12.14 (2025): 2412548. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1002/advs.202412548.
For Research Use Only. Not For Clinical Use.